Columbia University's Zuckerman Institute
Columbia’s Zuckerman Institute is dedicated to sharing the extraordinary research of our scientists with broad audiences.
https://zuckermaninstitute.columbia.edu/
https://zuckermaninstitute.columbia.edu/
Remdesivir vs. 3CLpro Inhibitor in SARS-CoV-2 Battle: Does 3CL Protease Inhibitor Have Superior Efficacy Compared to Remdesivir?
By
Columbia University's Zuckerman Institute
FEATURING
Meike Dittmann
By
Columbia University's Zuckerman Institute
FEATURING
Meike Dittmann
Comments 0
Login to view comments.
Click here to Login
